Clinical trials
Phase 2/3 Cognition Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AO GENERIUM | 1 |
| Carelon Research | 1 |
| Oregon Health and Science University | 1 |
| Swedish Herbal Institute AB | 1 |
| Yale University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognition Disorders | 5 |
| Cognitive Dysfunction | 2 |
| Fatigue | 2 |
| Anxiety Disorders | 1 |
| COVID-19 | 1 |
| Connective Tissue Diseases | 1 |
| Genetic Diseases, Inborn | 1 |
| Genetic Diseases, X-Linked | 1 |
| Headache | 1 |
| Heredodegenerative Disorders, Nervous System | 1 |
Trials
Showing 51 to 5 of 5. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.